Complete deliveries of CYFENDUS™ vaccine
Deadline passed; outcome being checked
- Announced
- 28 Nov 2023
- Due
- 31 Mar 2024
- Status
- Checking
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“be complete by the end of the first quarter of 2024”
What we found
The deadline has passed. We check for public evidence starting 30 days after the deadline, and repeat the check if nothing clear turns up.
Commitment lineage
Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.
- 1 versions
-
Version 1 · original · stated 28 Nov 2023
Deadline 31 Mar 2024 (“by the end of the first quarter of 2024”)
-
Version 2 · stated 8 Jan 2025
Deadline 30 Apr 2025 (“by April 2025”) · wording expected
“Deliveries are expected to begin this calendar year and be complete by April 2025.”
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Delivery
- Indicative materiality
- Medium rules
- Action
- Complete
- Deliverable
- CYFENDUS™ vaccine doses
- In the company’s control
- High
- Specificity
- High
- Depends on
- Customer
Tell me what happens
This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- OutcomeNot yet assessed. Nothing is judged before the deadline.
Are you Emergent BioSolutions Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2023-EBS-002488 · Corrections policy